InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

How will the joint venture affect InnovAge's revenue and profit growth in the short and long term? Will the joint venture lead to any changes in the company's capital structure or require additional financing? How will this joint venture impact InnovAge's earnings per share (EPS) guidance for the upcoming quarters? What are the integration and implementation timelines for the joint venture, and are there any milestones to watch? What regulatory approvals are required, and how might delays affect the expected benefits? How does this joint venture compare to similar partnerships in the PACE sector regarding valuation and market positioning? Will the joint venture affect InnovAge's cash flow, dividend policy, or share buyback plans? What are the potential risks and downside scenarios associated with the joint venture, including operational and regulatory risks? How will the partnership impact InnovAge's competitive positioning and market share in the PACE market? What impact will the joint venture have on the company's valuation multiples (e.g., P/E, EV/EBITDA) relative to peers? Are there any contingencies or earn-out provisions tied to the joint venture that could affect future financial performance? What synergies and cost savings are expected from the partnership with Tampa General Hospital?